Geny Piro

2.5k total citations
59 papers, 1.6k citations indexed

About

Geny Piro is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Geny Piro has authored 59 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 28 papers in Molecular Biology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Geny Piro's work include Pancreatic and Hepatic Oncology Research (21 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Geny Piro is often cited by papers focused on Pancreatic and Hepatic Oncology Research (21 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Geny Piro collaborates with scholars based in Italy, Japan and United States. Geny Piro's co-authors include Carmine Carbone, Giampaolo Tortora, Davide Melisi, Raffaela Santoro, Valeria Merz, Francesca Simionato, Camilla Zecchetto, Aldo Scarpa, Anna Tamburrino and Marco Zanotto and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Geny Piro

56 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geny Piro Italy 25 808 684 341 260 260 59 1.6k
Derya Duranyıldız Türkiye 22 603 0.7× 662 1.0× 294 0.9× 234 0.9× 282 1.1× 85 1.4k
Yoshito Terai Japan 29 1.1k 1.4× 697 1.0× 451 1.3× 187 0.7× 378 1.5× 136 2.7k
Eleonora Petrucci Italy 22 856 1.1× 358 0.5× 387 1.1× 205 0.8× 255 1.0× 35 1.6k
Michele Quaranta Italy 24 596 0.7× 644 0.9× 457 1.3× 198 0.8× 207 0.8× 57 1.6k
Long Yuan China 24 849 1.1× 640 0.9× 261 0.8× 189 0.7× 378 1.5× 56 1.7k
Shu‐Fen Chiang Taiwan 26 725 0.9× 694 1.0× 238 0.7× 202 0.8× 504 1.9× 55 1.6k
Hannes Neuwirt Austria 23 787 1.0× 548 0.8× 418 1.2× 483 1.9× 313 1.2× 62 1.8k
Juan A. Recio Spain 23 1.0k 1.3× 526 0.8× 215 0.6× 296 1.1× 179 0.7× 53 1.8k
Zhongyu Yuan China 23 743 0.9× 808 1.2× 610 1.8× 356 1.4× 182 0.7× 111 1.8k
Kyoung Min Kim South Korea 22 626 0.8× 606 0.9× 216 0.6× 397 1.5× 228 0.9× 65 1.4k

Countries citing papers authored by Geny Piro

Since Specialization
Citations

This map shows the geographic impact of Geny Piro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geny Piro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geny Piro more than expected).

Fields of papers citing papers by Geny Piro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geny Piro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geny Piro. The network helps show where Geny Piro may publish in the future.

Co-authorship network of co-authors of Geny Piro

This figure shows the co-authorship network connecting the top 25 collaborators of Geny Piro. A scholar is included among the top collaborators of Geny Piro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geny Piro. Geny Piro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carbone, Carmine, R. De Luca, Emanuele Puca, et al.. (2025). Antibody-based delivery of interleukin-2 modulates the immunosuppressive tumor microenvironment and achieves cure in pancreatic ductal adenocarcinoma syngeneic mice. Journal of Experimental & Clinical Cancer Research. 44(1). 7–7. 1 indexed citations
2.
3.
Luigetti, Marco, Ângela Romano, Valeria Guglielmino, et al.. (2024). Emerging multisystem biomarkers in hereditary transthyretin amyloidosis: a pilot study. Scientific Reports. 14(1). 18281–18281. 2 indexed citations
4.
Agostini, Antonio De, Geny Piro, Frediano Inzani, et al.. (2024). Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous Neoplasms. Nature Communications. 15(1). 2764–2764. 9 indexed citations
5.
Chiaravalli, Marta, et al.. (2022). Immunogenic Cell Death: An Emerging Target in Gastrointestinal Cancers. Cells. 11(19). 3033–3033. 34 indexed citations
6.
Luigetti, Marco, Ângela Romano, Valeria Guglielmino, et al.. (2022). Serum Inflammatory Profile in Hereditary Transthyretin Amyloidosis: Mechanisms and Possible Therapeutic Implications. Brain Sciences. 12(12). 1708–1708. 5 indexed citations
7.
Cencioni, Chiara, Ilaria Trestini, Geny Piro, et al.. (2022). Gastrointestinal Cancer Patient Nutritional Management: From Specific Needs to Novel Epigenetic Dietary Approaches. Nutrients. 14(8). 1542–1542. 25 indexed citations
8.
Piro, Geny, Carmine Carbone, Antonio Agostini, et al.. (2022). CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer. British Journal of Cancer. 128(2). 331–341. 19 indexed citations
9.
Carbone, Carmine, Geny Piro, Antonio Agostini, et al.. (2021). Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer. Journal for ImmunoTherapy of Cancer. 9(9). e002876–e002876. 49 indexed citations
10.
Merz, Valeria, Camilla Zecchetto, Raffaela Santoro, et al.. (2020). Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic Cancer. Clinical Cancer Research. 26(17). 4661–4669. 19 indexed citations
11.
Piro, Geny, Carmine Carbone, Luisa Carbognin, et al.. (2019). Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story. Cancers. 11(10). 1525–1525. 30 indexed citations
12.
Γκουντάκος, Αναστάσιος, Giulia Sartori, Italia Falcone, et al.. (2019). PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around. Cancers. 11(8). 1141–1141. 83 indexed citations
13.
Filippini, Dea, Pietro Delfino, Michele Simbolo, et al.. (2019). Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease. Scientific Reports. 9(1). 12286–12286. 24 indexed citations
14.
Carbone, Carmine, Geny Piro, Vincenzo Di Noia, et al.. (2019). Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer. Mediators of Inflammation. 2019. 1–10. 43 indexed citations
15.
Santoro, Raffaela, Marco Zanotto, Francesca Simionato, et al.. (2019). Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer. Molecular Cancer Therapeutics. 19(1). 247–257. 47 indexed citations
16.
Carbone, Carmine, Geny Piro, Valeria Merz, et al.. (2018). Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer. International Journal of Molecular Sciences. 19(2). 431–431. 161 indexed citations
17.
Piro, Geny, Carmine Carbone, Raffaela Santoro, Giampaolo Tortora, & Davide Melisi. (2018). Predictive biomarkers for the treatment of resectable esophageal and esophago-gastric junction adenocarcinoma: from hypothesis generation to clinical validation. Expert Review of Molecular Diagnostics. 18(4). 357–370. 4 indexed citations
18.
Cascetta, Priscilla, Alessandro Cavaliere, Geny Piro, et al.. (2018). Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance. International Journal of Molecular Sciences. 19(11). 3331–3331. 40 indexed citations
19.
Carbone, Carmine, Geny Piro, Francesca Simionato, et al.. (2017). Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients. Clinical Cancer Research. 23(15). 4312–4322. 41 indexed citations
20.
Melisi, Davide, Melissa Frizziero, Anna Tamburrino, et al.. (2014). Toll-Like Receptor 9 Agonists for Cancer Therapy. Biomedicines. 2(3). 211–228. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Derya Duranyıldız Breakdown of academic impact, for papers by Yoshito Terai Breakdown of academic impact, for papers by Eleonora Petrucci Breakdown of academic impact, for papers by Michele Quaranta Breakdown of academic impact, for papers by Long Yuan Breakdown of academic impact, for papers by Shu‐Fen Chiang Breakdown of academic impact, for papers by Hannes Neuwirt Breakdown of academic impact, for papers by Juan A. Recio Breakdown of academic impact, for papers by Zhongyu Yuan Breakdown of academic impact, for papers by Kyoung Min Kim
Rankless by CCL
2026